跳至主要内容
临床试验/CTRI/2019/09/021193
CTRI/2019/09/021193尚未招募未知

COMPARATIVE STUDY OF MYOPIA PROGRESSION IN SUBJECTS ON LOW DOSAGE OFATROPINE WITH MATCHED CONTROLS OF DIFFERENT AGE GROUPS

Centre for Sight0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age: 6 to 18 years
  • 2. Myopia >= 2.00 D (cycloplegic refraction; spherical equivalent) with or
  • without any astigmatism
  • 3. The minimum increase in refractive error should be 0.75DS in less
  • than 6 months.
  • 4. Provide written informed consent;
  • 5. No prior or current treatment for preventing myopia progression
  • (bifocals / progressive addition lenses / orthokeratology)
  • 6. Willingness and ability to follow all instructions and comply with
  • schedule for follow-up visits

排除标准

  • 1. Best corrected visual acuity < 6/18
  • 2. Simple myopic/hyperopic astigmatism with 0 spherical refractive error (Pure astigmatism)
  • 3. No prior or current treatment for preventing myopia progression (bifocals / progressive addition lenses / orthokeratology)
  • 4. Ocular diseases like Retinal dystrophy, Retinopathy of prematurity, Corneal opacities, keratoconus, Ocular hypertension / Glaucoma
  • 5. Prior intraocular surgery
  • 6. Allergy to atropine eye drops
  • 7. Lack of consent for participating in the study
  • 8. Systemic diseases associated with myopia such as Marfan syndrome, Stickler syndrome, Down syndrome, cardiac or significant respiratory diseases
  • 9. Those lost to follow-ups, lack of 80% compliance to Atropine 0.01% eyedrops
  • 10. In addition, the Investigator may exclude or discontinue any subject for any sound medical reason.

研究者

相似试验

ow dose Atropine for Myopia control | 临床试验